Blackstone to acquire Gramercy for $7.6bn

By Pouyan Broukhim
Share

The real estate arm of multinational private equity firm Blackstone has announced that it has agreed to acquire Gramercy Property Trust in a deal valued at $7.6bn.

The deal will further bolster the company's Blackstone Real Estate Partners division that has continued to grow into a leading market player in recent years.

See also:

“We are pleased to acquire Gramercy and its strong portfolio of assets,” said Tyler Henritze, Head of US Real Estate Acquisitions for Blackstone.

New York-based Gramercy will receive $27.50 per share in the transaction, representing a 23% premium compared to the company's 30-day average share price.

“We believe this validates the quality of the portfolio and platform that we have built,” said Gord DuGan, Trustee and Chief Executive Officer of Gramercy. “Entering into this transaction with Blackstone fulfills our Board of Trustees’ mission to maximize shareholder value.”

Morgan Stanley acted as Gramercy's financial advisor, whilst Citigroup and Bank of American Merrill Lynch acted as Blackstone's. The transaction is expected to close in H2 2018.

The deal comes just a few months after Blackstone agreed to acquire a majority 55% stake in Thomas Reuters' Financial & Risk Business for a fee of approximately $17bn.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy